DRY EYE: AWARD WINNING TECHNOLOGY SOLVES DILEMMA FOR PATIENTS Ardeo HealthT Licenses New Dry Eye Therapy From Novagali Pharma
Suwanee, GA, USA (June 15, 2011) - Ardeo Health, LLC, a biopharmaceutical development and licensing company, announced today that it has reached an agreement with Novagali Pharma S.A. of Evry, France to license Novagali's novel Nova23041 dry eye therapy for sale in the United States and Canada.